Journal of
Yeast and Fungal Research

  • Abbreviation: J. Yeast Fungal Res.
  • Language: English
  • ISSN: 2141-2413
  • DOI: 10.5897/JYFR
  • Start Year: 2010
  • Published Articles: 125

Full Length Research Paper

Susceptibility of Candida species isolated from recurrent vulvovaginal candidiasis to antifungal agents among women at Institut Pasteur of Côte d’Ivoire

Kpongbo Etienne Angora
  • Kpongbo Etienne Angora
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
Vincent Djohan
  • Vincent Djohan
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
Valérie A. Ira-Bonouman
  • Valérie A. Ira-Bonouman
  • Department of Parasitology and Mycology, Institut Pasteur of Côte d’Ivoire, 01 BP 490, Abidjan, Côte d’Ivoire.
  • Google Scholar
Henriette A. Vanga-Bosson
  • Henriette A. Vanga-Bosson
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
Kondo Fulgence Kassi
  • Kondo Fulgence Kassi
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
Abibatou Konaté
  • Abibatou Konaté
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
Valérie A. Bedia-Tanoh
  • Valérie A. Bedia-Tanoh
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
Sébastien A. Miezan
  • Sébastien A. Miezan
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
Christiane P. Kiki-Barro
  • Christiane P. Kiki-Barro
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
Hervé Menan
  • Hervé Menan
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar
André Offianan Touré
  • André Offianan Touré
  • Department of Parasitology and Mycology, Institut Pasteur of Côte d’Ivoire, 01 BP 490, Abidjan, Côte d’Ivoire.
  • Google Scholar
William Yavo
  • William Yavo
  • Department of Parasitology and Mycology, Faculty of Pharmacy, Felix Houphouët Boigny University, 01 BPV 34, Abidjan, Côte d’Ivoire.
  • Google Scholar


  •  Received: 11 August 2018
  •  Accepted: 02 October 2018
  •  Published: 31 October 2018

References

Amouri I, Abbes S, Sellami H, Makni F, Sellami A, Ayadi A (2010). La candidose vulvovaginale : Revue. 
Crossref

 

Arendrup MC (2013). Candida and candidaemia. Susceptibility and epidemiology. Danish Medical Journal 60:B4698.

 
 

Arfiputri DS, Hidayati AN, Handayani S, Ervianti E (2018). Risk factors of Vulvovaginal Candidiasis in Dermato-Venerology outpatients clinic of Soetomo General Hospital, Surabaya, Indonesia. African Journal of Infectious Diseases 12:90-94.
Crossref

 
 

Auler M, Morreira D, Rodrigues FF, Abr-Ao MS, Margarido PF, Matsumoto FE (2010). Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis. Medical Mycology 48:211-216.
Crossref

 
 

Bernstein JA, Seidu L (2015). Chronic vulvovaginal Candida hypersensitivity: An underrecognized and undertreated disorder by allergists. Allergy and rhinology 6:e44-e49.
Crossref

 
 

Bonouman-Ira V, Angora E, Djohan V, Vanga-Bosson H, Sylla-ThanonK, Beourou S, Touré AO, Faye-Ketté H, Dosso M, Koné M (2011). Profil de résistance des Candida non albicans à Abidjan en 2011. Revue Bio-Africa 9:27-31.

 
 

Brandolt TM, Klafke GB, Gonçalves CV, Bitencourt LR, Martinez AM, Mendes JF, Meireles, MC, Xavier MO (2017). Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Brazilian Journal of Microbiology (BJM) official publication of the Sociedade Brasileira de Microbiologia 48:145-150.

 
 

Corsello S, Spinillo A, Osnengo G, Penna C, Guaschino S, Beltrame A, Blasi N, Festa A (2003). An epidemiological survey of vulvovaginal candidiasis in Italy. European Journal of Obstetrics and Gynecology and Reproductive Biology 110:66-72.
Crossref

 
 

Crouss T, Sobel JD, Smith K, Nyirjesy P (2018). Long-Term outcomes of women with recurrent vulvovaginal candidiasis after a course of maintenance antifungal therapy. Journal of Lower Genital Tract Disease.
Crossref

 
 

Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R (2018). Global burden of recurrent vulvovaginal candidiasis: a systematic review. The Lancet Infectious Diseases. 
Crossref

 
 

Djohan V, Angora K., Vanga-Bosson A, Konaté A, Kassi F, Yavo W, Kiki-Barro P, Menan H, Koné M (2012). Sensibilité in vitro des souches de Candida albicans d'origine vaginale aux antifongiques à Abidjan (Côte d'Ivoire). Journal de Mycologie Médicale 22:129-133.
Crossref

 
 

Ekpenyong CE, Inyang-etoh EC, Ettebong EO, Akpan UP, Ibu JO, Daniel NE (2012). Recurrent vulvovaginal candidosis among young women in south eastern Nigeria: the role of lifestyle and health-care practices. International Journal of STD andAIDS 23:704-709.

 
 

Fan S, Liu X, Wu C, Xu L, Li J (2015). Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. Mycopathologia 179:95-101.
Crossref

 
 

Fidel P, Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, Quayle AJ, Dunlap K (2004). An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopthogenesis of vulvovaginal candidiasis. Infection and Immunity 72:2939-2946.
Crossref

 
 

Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E (2006). Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. European Journal of Obstetrics and Gynecology and Reproductive Biology 126:121-125.
Crossref

 
 

Grinceviciene S, Ruban K, Bellen G, Donders GG (2018). Sexual behaviour and extra-genital colonisation in women treated for recurrent Candida vulvo-vaginitis. Mycoses. 
Crossref

 
 

Hu Z, Zhou W, Yue XA, Mu LY, Jiang YM (2015). Dynamical evaluation of vaginal micro-ecosystem in a Chinese woman with recurrent vulvovaginal candidiasis. Genetics and Molecular Research 14:2626-2630.
Crossref

 
 

Khan M, Ahmed J, Gul A, Ikram A, Lalani FK (2018). Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar. Infection and Drug Resistance 11:447-456.
Crossref

 
 

Konaté A, Yavo W, Kassi FK, Djohan V, Angora EK, Barro-Kiki PC, Bosson-Vanga H, Soro F, Menan EH (2014). Aetiologies and contributing factors of vulvovaginal candidiasis in Abidjan (Cote d'Ivoire). Journal de Mycologie Médicale 24:93-99.
Crossref

 
 

Panizo MM, Reviákina V, Dolande M, Selgrad S (2009). Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Medical Mycology 47:137-143.
Crossref

 
 

Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA (2005). Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. Journal of Clinical Microbiology 43:2155-2162.
Crossref

 
 

Ringdahl EN (2000). Treatment of recurrent vulvovaginal candidiasis. American Family Physician 61:3306-3317.

 
 

Rylander E, Berglund AL, Krassny C, Petrini B (2004). Vulvovaginal Candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sexually Transmitted Infections 80:54-57.
Crossref

 
 

Shahid Z, Sobel JD (2009). Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy. Diagnostic Microbiology and Infectious Disease 64:354-356.
Crossref

 
 

Sobel J (2015). Recurrent vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology 15:714-716.

 
 

Sobel JD (2007). Vulvovaginal candidosis. Lancet (London, England) 369:1961–1971.
Crossref

 
 

Sobel JD, Sobel R (2018). Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opinion on Pharmacotherapy 19:971-977.
Crossref

 
 

Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC (2004). Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. The New England Journal of Medicine 351:876-883.
Crossref